4//SEC Filing
GOLDBERG MORTON 4
Accession 0001104659-20-022844
CIK 0001372514other
Filed
Feb 18, 7:00 PM ET
Accepted
Feb 19, 4:31 PM ET
Size
5.4 KB
Accession
0001104659-20-022844
Insider Transaction Report
Form 4
GOLDBERG MORTON
Director
Transactions
- Award
Stock Option (right to buy)
2020-02-14+3,333→ 3,333 totalExercise: $6.55Exp: 2030-02-14→ Common Stock (3,333 underlying)
Footnotes (1)
- [F1]The Reporting Person received an Option to purchase Common Stock from the Issuer pursuant to the Plan. The Option will become fully exercisable on February 1, 2021.
Documents
Issuer
EYEGATE PHARMACEUTICALS INC
CIK 0001372514
Entity typeother
Related Parties
1- filerCIK 0001619731
Filing Metadata
- Form type
- 4
- Filed
- Feb 18, 7:00 PM ET
- Accepted
- Feb 19, 4:31 PM ET
- Size
- 5.4 KB